Need to file an Actos lawsuit? Contact Williams Kherkher today at 800-641-9810.

FDA studies lead Actos to add bladder cancer to warning labels

Posted on September 19th, 2011 No Comments

This month, the makers of the Type 2 diabetes drug, Actos, announced that they are adding the risk of bladder cancer onto Actos warning labels.

The announcement comes shortly after the Food and Drug Administration released the results of a large-scale study into the increased risk of bladder cancer for people taking Actos.

The FDA study examined more than 193,000 patients taking Actos for an average of 2 years.  According to the study, Type 2 diabetes patients taking Actos for “longer than 12 months were associated with a 40 percent increase in risk [for bladder cancer].”

The FDA now advises doctors to not prescribe the drug to patients who have bladder cancer or who have had bladder cancer in the past.

If you or someone you love developed bladder cancer after taking Actos to treat Type 2 diabetes, contact the Actos lawsuit attorneys of Williams Kherkher at 800-641-9810 to learn more about how we can help you.

Tagged , | Leave a comment

Contact Williams Kherkher

By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.

home  |  about us  |  attorneys  |  actos  |  bladder cancer  |  faqs  |  articles  |  law resources  |  press release  |  contact us  |  blog  |  Log in
Copyright ©2007-2010 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-641-9810 | John Eddie Williams +